Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses.

Abstract:

:Umbilical cord blood (CB) from the early gestational human fetus is recognized as a rich source of hematopoietic stem cells. To examine the value of fetal CB for gene therapy of inborn immunohematopoietic disorders, we tested the feasibility of genetic modification of CD34(+) cells from CB at weeks 24 to 34 of pregnancy, using lentiviral vector-mediated transfer of the green fluorescent protein (GFP) gene. The transduction rate of CD34(+) cells was 42 +/- 9%, resulting in GFP expression in 23 +/- 4% of colonies derived from colony-forming units (CFUs) and 11 +/- 1% from primitive long-term culture-initiating cells (LTC-ICs). Cell cycle analysis demonstrated transduction and GFP expression in cells in the G(0) phase, which contains immature hematopoietic progenitors. Transduced fetal CD34(+) cells could be expanded 1000-fold in long-term cultures supplemented with megakaryocyte growth and development factor along with Flt-3 ligand. At week 10, expression of GFP was observed in 40.5 +/- 11.7% of CFU-derived colonies. While prestimulation of CD34(+) cells with cytokines prior to transduction increased the efficiency of GFP transfer 2- to 3-fold, long-term maintenance of GFP-expressing CFUs occurred only in the absence of prestimulation. The GFP gene was found integrated into the genomic DNA of 35% of LTC-IC-derived colonies initiated at week 10, but GFP expression was not detectable, suggesting downregulation of transgene activity during the extended culture period. These results indicate that human fetal CB progenitors are amenable to genetic modification by lentiviral vectors and may serve as a target for gene therapy of hematopoietic disorders by prenatal autologous transplantation.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Luther-Wyrsch A,Costello E,Thali M,Buetti E,Nissen C,Surbek D,Holzgreve W,Gratwohl A,Tichelli A,Wodnar-Filipowicz A

doi

10.1089/10430340150504000

keywords:

subject

Has Abstract

pub_date

2001-03-01 00:00:00

pages

377-89

issue

4

eissn

1043-0342

issn

1557-7422

journal_volume

12

pub_type

杂志文章
  • Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes.

    abstract::Adenovirus-polylysine-DNA complexes were evaluated for their capacity to accomplish direct in vivo gene transfer to airway epithelium employing a rodent model. Binary complexes containing transferrin or adenovirus, or combination complexes containing both transferrin and adenovirus, were evaluated. The highest in vitr...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1993.4.1-17

    authors: Gao L,Wagner E,Cotten M,Agarwal S,Harris C,Rømer M,Miller L,Hu PC,Curiel D

    更新日期:1993-02-01 00:00:00

  • In vivo marking of spontaneous or vaccine-induced fibrosarcomas in the domestic house cat, using an adenoviral vector containing a bifunctional fusion protein, GAL-TEK.

    abstract::We evaluated the ability of a replication-deficient, recombinant adenoviral vector to transfer the bifunctional gene GAL-TEK, which expresses a marking/therapeutic gene product, to naturally occurring cat fibrosarcomas in situ. GAL-TEK contains an in-frame fusion of the bacterial LacZ gene for histochemical marking of...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1995.6.9-1215

    authors: Marini FC 3rd,Cannon JP,Belmont JW,Shillitoe EJ,Lapeyre JN

    更新日期:1995-09-01 00:00:00

  • Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.

    abstract::The transfer of a drug resistance gene into hematopoietic cells is an approach being investigated to overcome the problem of myelosuppression produced by anticancer drugs. Chemotherapeutic agents are often given in combination in order to increase their effectiveness. Consequently, there is an advantage in designing v...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.17-2537

    authors: Beauséjour CM,Le NL,Létourneau S,Cournoyer D,Momparler RL

    更新日期:1998-11-20 00:00:00

  • Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.

    abstract::To develop a potential gene therapy strategy for the treatment of hemophilia A, we constructed several retroviral vectors expressing a B-domain-deleted factor VIII (FVIII) cDNA. We confirmed previous reports that when the FVIII cDNA is inserted into a retroviral vector, the vector mRNA is decreased resulting in signif...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1995.6.11-1363

    authors: Chuah MK,VandenDriessche T,Morgan RA

    更新日期:1995-11-01 00:00:00

  • FUT-175, a synthetic inhibitor of the complement pathway, protects against the inactivation of infectious retroviruses by human serum.

    abstract::Serum-induced inactivation of retroviruses is the most critical limitation for in vivo gene transfer therapy. To solve this problem, we searched for reagents that protect retroviruses from inactivation. The effects of the protease inhibitors FOY-007 and FOY-305 and of an inhibitor of the complement pathway FUT-175, al...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.13-1575

    authors: Miyao Y,Ikenaka K,Kishima H,Tamura M,Nakamura K,Kurumi M,Hayakawa T,Shimizu K

    更新日期:1997-09-01 00:00:00

  • A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

    abstract::This Phase I study, "Ribozyme Gene Therapy of HIV-1 Infection" (UCSD HSC #971072, FDA BB-IND 6405), is a prospective, open-label trial of infusion of autologous gene-altered cells into asymptomatic HIV-1 seropositive individuals. The objectives of this trial are to test the safety, feasibility, and potential efficacy ...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章

    doi:10.1089/hum.1998.9.16-2407

    authors: Wong-Staal F,Poeschla EM,Looney DJ

    更新日期:1998-11-01 00:00:00

  • Randomized Clinical Trials of Gene Transfer for Heart Failure with Reduced Ejection Fraction.

    abstract::Despite improvements in drug and device therapy for heart failure, hospitalization rates and mortality have changed little in the past decade. Randomized clinical trials using gene transfer to improve function of the failing heart are the focus of this review. Four randomized clinical trials of gene transfer in heart ...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2016.166

    authors: Penny WF,Hammond HK

    更新日期:2017-05-01 00:00:00

  • Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results.

    abstract::MDA-MB-231, an HLA-A2(+), HER2/neu(+) allogeneic breast cancer cell line genetically modified to express the costimulatory molecule CD80 (B7-1), was used to vaccinate 30 women with previously treated stage IV breast cancer. Expression of CD80 conferred the ability to deliver a costimulatory signal and thereby improved...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章

    doi:10.1089/104303403322124828

    authors: Dols A,Smith JW 2nd,Meijer SL,Fox BA,Hu HM,Walker E,Rosenheim S,Moudgil T,Doran T,Wood W,Seligman M,Alvord WG,Schoof D,Urba WJ

    更新日期:2003-07-20 00:00:00

  • The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite.

    abstract::The bystander effect is an important part of tumor kill using gene-directed enzyme prodrug therapy (GDEPT). Recently, we have described a novel enzyme prodrug system using bacterial nitroreductase and the prodrug CB1954 (NTR/CB1954). We demonstrate here the presence of a cell-permeable cytotoxic activity in the condit...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1997.8.6-709

    authors: Bridgewater JA,Knox RJ,Pitts JD,Collins MK,Springer CJ

    更新日期:1997-04-10 00:00:00

  • Endothelial Progenitor Cells as Shuttle of Anticancer Agents.

    abstract::Cell therapies are treatments in which stem or progenitor cells are stimulated to differentiate into specialized cells able to home to and repair damaged tissues. After their discovery, endothelial progenitor cells (EPCs) stimulated worldwide interest as possible vehicles to perform autologous cell therapy of tumors. ...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2016.066

    authors: Laurenzana A,Margheri F,Chillà A,Biagioni A,Margheri G,Calorini L,Fibbi G,Del Rosso M

    更新日期:2016-10-01 00:00:00

  • Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.

    abstract::Newcastle disease virus (NDV) is a naturally oncolytic virus that has been shown to be safe and effective for cancer therapy. Tumor virotherapy using NDV emerged in the 1950s and has advanced more recently by the increased availability of reverse genetics technology. In this study, we constructed a reverse genetics sy...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2011.207

    authors: Wei D,Sun N,Nan G,Wang Y,Liu HQ,Peeters B,Chen ZN,Bian H

    更新日期:2012-07-01 00:00:00

  • Efficient bone marrow transduction by gene transfer with allogeneic umbilical cord blood serum and plasma: an implication for clinical trials.

    abstract::Low in vivo transduction efficiency and safety concerns have been hurdles for effective hematopoietic stem cell (HSC) gene therapy. Here, we investigate whether the safety and efficiency of retroviral gene transfer into HSCs can be improved by using human allogeneic umbilical cord blood (UCB)-derived supplements inste...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2007.123

    authors: Moon N,Yang SJ,Park BB,Chung YS,Lee JW,Oh IH

    更新日期:2008-07-01 00:00:00

  • Characterization of lentiviral vector-mediated gene transfer in adult mouse brain.

    abstract::Lentiviral vectors are promising tools for gene transfer into the central nervous system. We have characterized in detail transduction with human immunodeficiency virus type 1 (HIV-1)-derived vectors encoding enhanced green fluorescent protein (eGFP) in the adult mouse brain. Different brain regions such as the striat...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340252899019

    authors: Baekelandt V,Claeys A,Eggermont K,Lauwers E,De Strooper B,Nuttin B,Debyser Z

    更新日期:2002-05-01 00:00:00

  • Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium.

    abstract::The influence of serum on the production of retroviral vectors by the HT1080 human fibrosarcoma-derived packaging cell line FLYRD18 was investigated. A fourfold increase in virus titer was observed under serum-free conditions, as compared with medium supplemented with 10% fetal calf serum. A similar improvement was al...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950017329

    authors: Gerin PA,Gilligan MG,Searle PF,Al-Rubeai M

    更新日期:1999-08-10 00:00:00

  • MALAT1-Driven Inhibition of Wnt Signal Impedes Proliferation and Inflammation in Fibroblast-Like Synoviocytes Through CTNNB1 Promoter Methylation in Rheumatoid Arthritis.

    abstract::Fibroblast-like synoviocytes (FLSs) participate in the pathogenesis of rheumatoid arthritis (RA). Emerging evidence has highlighted the role of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) and its potential involvement in RA. In this study, we test the hypothesis that the MALAT1 ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2018.212

    authors: Li GQ,Fang YX,Liu Y,Meng FR,Wu X,Zhang CW,Zhang Y,Liu D,Gao B

    更新日期:2019-08-01 00:00:00

  • Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.

    abstract::Kallistatin is a serine proteinase inhibitor that has been shown to reduce joint swelling and to inhibit inflammation in a rat model of arthritis. In this study, we investigated the effect and mechanisms of kallistatin on cardiac function after myocardial ischemia-reperfusion (I/R) injury. The human kallistatin gene i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.1201

    authors: Chao J,Yin H,Yao YY,Shen B,Smith RS Jr,Chao L

    更新日期:2006-12-01 00:00:00

  • Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral delivery.

    abstract::Duchenne muscular dystrophy (DMD) is a lethal genetic disorder for which there is currently no effective treatment. Although clinical application of adenoviral vector-mediated gene transfer has not been fully developed, it shows promise for the treatment of DMD. One significant problem posed by adenoviral vector-media...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1995.6.11-1477

    authors: Clemens PR,Krause TL,Chan S,Korb KE,Graham FL,Caskey CT

    更新日期:1995-11-01 00:00:00

  • Fusion of the human immunodeficiency virus type 1 tat protein transduction domain to thymidine kinase increases bystander effect and induces enhanced tumor killing in vivo.

    abstract::The clinical success of suicide gene therapy using herpes simplex virus type 1 thymidine kinase (TK) is largely dependent on the capacity of this enzyme to effectively induce the death of bystander cells. We have shown that fusion of TK to an 11-amino acid peptide from the basic domain of the human immunodeficiency vi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.1389

    authors: Tasciotti E,Giacca M

    更新日期:2005-12-01 00:00:00

  • Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors.

    abstract::Gene therapy for Duchenne muscular dystrophy will likely require that the corrective dystrophin gene be delivered to a high fraction of muscle fibers in vivo. Because of the large size of the dystrophin cDNA, adenoviral (Ad) vectors have been developed for this application. However, Ad vectors transduce mature muscle ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2006.17.314

    authors: Menezes KM,Mok HS,Barry MA

    更新日期:2006-03-01 00:00:00

  • Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes.

    abstract::The use of gene-engineered T cells expressing chimeric single-chain (scFv) receptors capable of codelivering CD28 costimulation and T cell receptor zeta chain (TCR-zeta) activation signals has emerged as a promising treatment regimen for cancer. Using retroviral transduction, primary human T lymphocytes were gene-engi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/1043034041361235

    authors: Teng MW,Kershaw MH,Moeller M,Smyth MJ,Darcy PK

    更新日期:2004-07-01 00:00:00

  • Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates.

    abstract::An E1-, E2a-, E3-deleted adenoviral vector (Av3H82) encoding an epitope-tagged B domain-deleted human factor VIII cDNA (flagged FVIII) was evaluated in nonhuman primates. Twelve cynomolgus monkeys received intravenous administration of Av3H82; 6 monkeys received 6 x 10(11) particles/kg and another 6 received 3 x 10(12...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950016401

    authors: Brann T,Kayda D,Lyons RM,Shirley P,Roy S,Kaleko M,Smith T

    更新日期:1999-12-10 00:00:00

  • Intravenous AAV8 Encoding Urocortin-2 Increases Function of the Failing Heart in Mice.

    abstract::Urocortin-2 (UCn2) peptide infusion increases cardiac function in patients with heart failure, but chronic peptide infusion is cumbersome, is costly, and provides only short-term benefits. Gene transfer would circumvent these shortcomings. We previously showed that a single intravenous (IV) injection of AAV8.UCn2 incr...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2014.157

    authors: Lai NC,Gao MH,Giamouridis D,Suarez J,Miyanohara A,Parikh J,Hightower S,Guo T,Dillmann W,Kim YC,Diaz-Juarez J,Hammond HK

    更新日期:2015-06-01 00:00:00

  • Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particles.

    abstract::Recombinant adeno-associated viral (AAV) vectors of serotypes 6, 8, and 9 were characterized as tools for gene delivery to dopaminergic neurons in the substantia nigra for future gene therapeutic applications in Parkinson's disease. While vectors of all three serotypes transduced nigral dopaminergic neurons with equal...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2012.174

    authors: Löw K,Aebischer P,Schneider BL

    更新日期:2013-06-01 00:00:00

  • Adenovirus-mediated transfer of an Na+/K+-ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats.

    abstract::Pulmonary edema is cleared via active Na(+) transport by alveolar epithelial Na(+)/K(+)-ATPases and Na(+) channels. Rats exposed to acute hyperoxia have a high mortality rate, decreased Na(+)/K(+)-ATPase function, and decreased alveolar fluid clearance (AFC). We hypothesized that Na(+)/K(+)-ATPase subunit gene overexp...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303400750035753

    authors: Factor P,Dumasius V,Saldias F,Brown LA,Sznajder JI

    更新日期:2000-11-01 00:00:00

  • Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial.

    abstract::Recombinant vectors based on adeno-associated virus serotype 8 (AAV8) have been successfully used in the clinic and hold great promise for liver-directed gene therapy. Preexisting immunity against AAV8 or the development of antibodies against the therapeutic transgene product might negatively affect the outcomes of ge...

    journal_title:Human gene therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1089/hum.2014.109

    authors: Ferla R,Claudiani P,Savarese M,Kozarsky K,Parini R,Scarpa M,Donati MA,Sorge G,Hopwood JJ,Parenti G,Fecarotta S,Nigro V,Sivri HS,Van Der Ploeg A,Andria G,Brunetti-Pierri N,Auricchio A

    更新日期:2015-03-01 00:00:00

  • Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy.

    abstract::Oncolytic measles virus (MV) encoding the human thyroidal sodium iodide symporter (MV-NIS) has proved to be safe after intraperitoneal or intravenous administration in patients with ovarian cancer or multiple myeloma, respectively, but it has not yet been administered through intratumoral injection in humans. Squamous...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2011.128

    authors: Li H,Peng KW,Russell SJ

    更新日期:2012-03-01 00:00:00

  • Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.

    abstract::Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) offer great hope for in vitro modeling of Parkinson's disease (PD), as well as for designing cell-replacement therapies. To realize these opportunities, there is an urgent need to develop efficient protocols for the directed differentiation of...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2011.054

    authors: Sánchez-Danés A,Consiglio A,Richaud Y,Rodríguez-Pizà I,Dehay B,Edel M,Bové J,Memo M,Vila M,Raya A,Izpisua Belmonte JC

    更新日期:2012-01-01 00:00:00

  • Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules.

    abstract::Somatic gene therapy using nonautologous recombinant cells immunologically protected with alginate microcapsules has been successfully used to treat rodent genetic diseases. We now report the delivery of recombinant gene products to the brain in rodents by implanting microencapsulated cells for the purpose of eventual...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950019183

    authors: Ross CJ,Ralph M,Chang PL

    更新日期:1999-01-01 00:00:00

  • Pharmacological regulation of the insulin receptor signaling pathway mimics insulin action in cells transduced with viral vectors.

    abstract::Diabetes mellitus derives from either insulin deficiency (type I) or resistance (type II). Homozygous mutations in the insulin receptor (IR) gene cause the rare leprechaunism and Rabson-Mendenhall syndromes, severe forms of hyperinsulinemic insulin resistance for which no therapy is currently available. Systems have b...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2004.15.1101

    authors: Cotugno G,Pollock R,Formisano P,Linher K,Beguinot F,Auricchio A

    更新日期:2004-11-01 00:00:00

  • Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.

    abstract::Therapeutic levels of expression of the beta-globin gene have been difficult to achieve with conventional retroviral vectors without the inclusion of DNase I-hypersensitive site (HS2, HS3, and HS4) enhancer elements. We generated recombinant adeno-associated viral (AAV) vectors carrying an antisickling human beta-glob...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2007.173

    authors: Maina N,Zhong L,Li X,Zhao W,Han Z,Bischof D,Aslanidi G,Zolotukhin S,Weigel-Van Aken KA,Rivers AE,Slayton WB,Yoder MC,Srivastava A

    更新日期:2008-04-01 00:00:00